NLRP3 and glomerulosclerosis: These results indicate that an imbalance of lysosome-dependent sphingolipid metabolism may be the molecular mechanism initiating NLRP3 inflammasome activation in podocytes, leading to podocyte injury and glomerular sclerosis during hHcy.